Navigation Links
Gladstone's Shinya Yamanaka wins prestigious Shaw Prize

SAN FRANCISCO, CA June 11, 2008 The J. David Gladstone Institutes today announced that senior investigator Shinya Yamanaka, MD, PhD, also of Kyoto University and UCSF, has been awarded the prestigious Shaw Prize for his contributions in reprogramming adult skin cells to pluripotent, embryonic-like stem cells. He will receive half of the $1 million award. Cloning pioneers Ian Wilmut and Keith Campbell will split the other half of the prize for their landmark generation of the now famous sheep, Dolly.

"Dr. Yamanaka's discoveries have dramatically accelerated the pace of stem cell research and the development of this technology for regenerative therapies," said Gladstone president Robert W. Mahley, MD, PhD. "We're proud that our colleague has received this international honor."

Dr. Yamanaka and his Kyoto University laboratory demonstrated in 2006 that the addition of just four genes could convert adult mouse skin cells back to embryonic-like stem cells, which he called induced pluripotent stem (iPS) cells. The iPS cells could turn into all of the different cell types of the body and appeared to have the same properties as embryonic stem cells. Importantly, the pluripotent cells were made without the need to generate an embryo, obviating many of the ethical concerns around stem cell biology. Then in 2007, Dr. Yamanaka's laboratory created iPS cells from human skin cells in a similar fashion. Dr. Yamanaka's discoveries have opened a new field of science and represent a quantum leap forward in stem cell biology.

The Shaw Prize, established under the auspices of Mr. Run Run Shaw in November 2002, is an international award to honor individuals who are currently active in their respective fields and who have made outstanding contributions in the biomedical sciences and innovations in clinical medicine.

"The landmark contributions by these scientists who are honored with the Shaw Prize have thereby ushered in a new era in stem cell research, with huge potential benefits to mankind." said the Shaw Prize Foundation.


Contact: Valerie Tucker
Gladstone Institutes

Related biology news :

1. Monash researcher receives prestigious Commonwealth Health Ministers award
2. Harold Mooney wins prestigious Tyler Prize for Environmental Achievement
3. Dr. John Polanyi wins Canadas most prestigious science award
4. ESFs European ice core project EPICA receives prestigious Descartes Prize
5. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
6. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
7. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
8. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
9. UC Riverside biologist receives prestigious MacArthur Fellowship
10. RSC Project Prospect scoops prestigious award
11. Spradling receives Gruber Foundation Genetics Prize for new genetic techniques
Post Your Comments:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... ... 27, 2016 , ... Parallel 6 , the leading software as a ... Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine ... team. , Using the CONSULT module, patients and physicians can schedule a face to ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology: